Produkty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EFTA należące do EOG w pierwszym półroczu 2008 r.
Dz.U.UE.C.2009.52.11
Akt nienormatywny(2009/C 52/05)
(Dz.U.UE C z dnia 5 marca 2009 r.)
Podkomitet I - Ds. swobodnego przepływu towarów
Do wiadomości Wspólnego Komitetu EOG
W nawiązaniu do decyzji Wspólnego Komitetu EOG nr 74/1999 z dnia 28 maja 1999 r. Wspólnemu Komitetowi EOG przekazuje się celem przyjęcia do wiadomości na posiedzeniu w dniu 7 listopada 2008 r. następujące wykazy dotyczące pozwoleń na dopuszczenie do obrotu produktów leczniczych za okres od dnia 1 stycznia do dnia 30 czerwca 2008 r.:
ZAŁĄCZNIKI
ZAŁĄCZNIK I
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data wydania pozwolenia |
EU/1/05/312/001 | Xyrem | Liechtenstein | 30.6.2008 |
EU/1/06/334/001-004 | Evoltra | Liechtenstein | 30.6.2008 |
EU/1/06/370/001-024 | Exforge | Liechtenstein | 30.6.2008 |
EU/1/06/371/001-024 | Dafiro | Liechtenstein | 30.6.2008 |
EU/1/06/372/001-024 | Copalia | Liechtenstein | 30.6.2008 |
EU/1/06/373/001-024 | Imprida | Liechtenstein | 30.6.2008 |
EU/1/07/001-019/IS | Retacrit | Islandia | 16.1.2008 |
EU/1/07/393/001 | Soliris | Liechtenstein | 30.6.2008 |
EU/1/07/400/001-016 | Mircera | Liechtenstein | 30.6.2008 |
EU/1/07/402/001/NO | Increlex | Norwegia | 31.1.2008 |
EU/1/07/421/001-009/IS | Pioglitazone | Islandia | 9.1.2008 |
EU/1/07/422/001/NO-004/NO | Tasigna | Norwegia | 17.1.2008 |
EU/1/07/422/001-004 | Tasigna | Liechtenstein | 30.6.2008 |
EU/1/07/423/001/NO-003/NO | Vectibix | Norwegia | 21.1.2008 |
EU/1/07/423/001-003 | Vectibix | Liechtenstein | 30.6.2008 |
EU/1/07/423/001-003/IS | Vectibix | Islandia | 28.1.2008 |
EU/1/07/427/001/NO-037/NO | Olanzapine Teva | Norwegia | 7.1.2008 |
EU/1/07/427/001-047/IS | Olanzapine Teva | Islandia | 7.1.2008 |
EU/1/07/428/001 | Abraxane | Liechtenstein | 29.2.2008 |
EU/1/07/428/001/IS | Abraxane | Islandia | 24.1.2008 |
EU/1/07/428/001/NO | Abraxane | Norwegia | 21.1.2008 |
EU/1/07/430/001 | Atripla | Liechtenstein | 30.6.2008 |
EU/1/07/430/001/IS | Atripla | Islandia | 28.1.2008 |
EU/1/07/430/001/NO | Atripla | Norwegia | 29.1.2008 |
EU/1/07/431/001/NO-019/NO | Retacrit | Norwegia | 17.1.2008 |
EU/1/07/431/001-019 | Retacrit | Liechtenstein | 30.6.2008 |
EU/1/07/432/001/NO-019/NO | Silapo | Norwegia | 17.1.2008 |
EU/1/07/432/001-019 | Silapo | Liechtenstein | 29.2.2008 |
EU/1/07/432/001-019/IS | Silapo | Islandia | 16.1.2008 |
EU/1/07/433/001/IS | Nevanac | Islandia | 8.1.2008 |
EU/1/07/434/001/NO-003/NO | Avamys | Norwegia | 23.1.2008 |
EU/1/07/434/001-003 | Avamys | Liechtenstein | 29.2.2008 |
EU/1/07/434/001-003/IS | Avamys | Islandia | 25.1.2008 |
EU/1/07/435/001/NO-018/NO | Tesavel | Norwegia | 24.1.2008 |
EU/1/07/435/001-018 | Tesavel | Liechtenstein | 30.4.2008 |
EU/1/07/435/001-018/IS | Tesavel | Islandia | 24.1.2008 |
EU/1/07/436/001/NO-002/NO | Isentress | Norwegia | 16.1.2008 |
EU/1/07/436/001-002 | Isentress | Liechtenstein | 29.2.2008 |
EU/1/07/436/001-002/IS | Isentress | Islandia | 18.1.2008 |
EU/1/07/437/001/NO-002/NO | Ivemend | Norwegia | 31.1.2008 |
EU/1/07/437/001-002 | Ivemend | Liechtenstein | 29.2.2008 |
EU/1/07/437/001-002/IS | Ivemend | Islandia | 22.1.2008 |
EU/1/07/438/001/NO-004/NO | Myfenac | Norwegia | 14.3.2008 |
EU/1/07/438/001-004 | Myfenax | Liechtenstein | 30.4.2008 |
EU/1/07/438/001-004/IS | Myfenax | Islandia | 17.3.2008 |
EU/1/07/439/001/NO-004/NO | Mycophenolatemofetil Teva | Norwegia | 14.3.2008 |
EU/1/07/439/001-004 | Mycophenolatemofetil Teva | Liechtenstein | 30.4.2008 |
EU/1/07/439/001-004/IS | Mycophenolatemofetil Teva | Islandia | 17.3.2008 |
EU/1/07/440/001/NO-002/NO | Tyverb | Norwegia | 17.6.2008 |
EU/1/07/440/001-002/IS | Tyverb | Islandia | 26.6.2008 |
EU/1/08/441/001/NO-010/NO | Effentora | Norwegia | 15.4.2008 |
EU/1/08/441/001-010 | Effentora | Liechtenstein | 30.4.2008 |
EU/1/08/441/001-010/IS | Effentora | Islandia | 17.4.2008 |
EU/1/08/442/001/NO-008/NO | Pradaxa | Norwegia | 14.4.2008 |
EU/1/08/442/001-008 | Pradaxa | Liechtenstein | 30.4.2008 |
EU/1/08/442/001-008/IS | Pradaxa | Islandia | 26.3.2008 |
EU/1/08/443/001 | Thalidomide Pharmion | Liechtenstein | 30.4.2008 |
EU/1/08/443/001/IS | Thalidomide Pharmion | Islandia | 21.4.2008 |
EU/1/08/443/001/NO | Thalidomide Pharmion | Norwegia | 16.5.2008 |
EU/1/08/446/001/NO-003/NO | Privigen | Norwegia | 19.5.2008 |
EU/1/08/446/001-003 | Privigen | Liechtenstein | 30.6.2008 |
EU/1/08/446/001-003/IS | Privigen | Islandia | 23.5.2008 |
EU/1/08/447/001/NO-004/NO | Adenuric | Norwegia | 24.6.2008 |
EU/1/08/447/001-004 | Adenuric | Liechtenstein | 30.4.2008 |
EU/1/08/447/001-004/IS | Adenuric | Islandia | 16.5.2008 |
EU/1/08/448/001/NO-002/NO | Mycamine | Norwegia | 21.5.2008 |
EU/1/08/448/001-002 | Mycamine | Liechtenstein | 30.4.2008 |
EU/1/08/448/001-002/IS | Mycamine | Islandia | 28.5.2008 |
EU/1/08/451/001/NO-004/NO | Volibris | Norwegia | 29.4.2008 |
EU/1/08/451/001-002/IS | Volibris | Islandia | 21.5.2008 |
EU/1/08/451/001-004 | Volibris | Liechtenstein | 30.4.2008 |
EU/1/08/452/001 | Pandemrix | Liechtenstein | 30.6.2008 |
EU/1/08/452/001/IS | Pandemrix | Islandia | 23.5.2008 |
EU/1/08/452/001/NO | Pandemrix | Norwegia | 20.5.2008 |
EU/1/08/453/001 | Prepandrix | Liechtenstein | 30.6.2008 |
EU/1/08/453/001/IS | Prepandrix | Islandia | 23.5.2008 |
EU/1/08/454/001/NO-004/NO | Extavia | Norwegia | 3.6.2008 |
EU/1/08/454/001-004 | Extavia | Liechtenstein | 30.6.2008 |
EU/1/08/454/001-004/IS | Extavia | Islandia | 30.5.2008 |
EU/2//08/081/001-003 | Posatex | Liechtenstein | 30.6.2008 |
EU/2/04/044/007/IS | Aivlosin | Islandia | 19.6.2008 |
EU/2/07/073/001/NO-004/NO | Nobilis Influenza H7N1 | Norwegia | 4.1.2008 |
EU/2/07/076/001/NO-004/NO | Nobilis Influenza H5N6 | Norwegia | 13.3.2008 |
EU/2/07/076/001-004 | Nobilis Influenza H5N6 | Liechtenstein | 29.2.2008 |
EU/2/07/077/001/NO-005/NO | Meloxivet | Norwegia | 7.2.2008 |
EU/2/07/077/001-004/IS | Meloxivet | Islandia | 27.6.2008 |
EU/2/07/078/001/NO-003/NO | Rheumocam | Norwegia | 25.2.2008 |
EU/2/07/078/001-002/IS | Rheumocam | Islandia | 25.1.2008 |
EU/2/07/078/001-003 | Rheumocam | Liechtenstein | 29.2.2008 |
EU/2/07/079/001/NO-004/NO | Ingelvac CircoFLEX | Norwegia | 26.3.2008 |
EU/2/07/079/001-004 | Ingelvac CircoFLEX | Liechtenstein | 29.2.2008 |
EU/2/07/079/001-004/IS | Ingelvac CircoFLEX | Islandia | 19.3.2008 |
ZAŁĄCZNIK II
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data wydania pozwolenia |
EU/1/02/246/001/NO-003/NO | Carbaglu | Norwegia | 30.5.2008 |
EU/1/02/246/001-003 | Carbaglu | Liechtenstein | 30.6.2008 |
EU/1/02/246/001-003/IS | Carbaglu | Islandia | 29.5.2008 |
EU/1/03/247/001/NO-002/NO | Forsteo | Norwegia | 1.7.2008 |
EU/1/03/247/001-002 | Forsteo | Liechtenstein | 30.6.2008 |
EU/1/03/247/001-002/IS | Forsteo | Islandia | 21.5.2008 |
EU/1/03/248/001/NO-012/NO | Levitra | Norwegia | 25.2.2008 |
EU/1/03/248/001-012/IS | Levitra | Islandia | 19.2.2008 |
EU/1/03/249/001/NO-012/NO | Vivanza | Norwegia | 25.2.2008 |
EU/1/03/249/001-012 | Vivanza | Liechtenstein | 29.2.2008 |
EU/1/03/249/001-012/IS | Vivanza | Islandia | 19.2.2008 |
EU/1/03/250/001 | Ytracis | Liechtenstein | 29.2.2008 |
EU/1/03/250/001/IS | Ytracis | Islandia | 28.2.2008 |
EU/1/03/250/001/NO | Ytracis | Norwegia | 25.2.2008 |
EU/1/03/251/001/NO-002/NO | Hepsera | Norwegia | 4.4.2008 |
EU/1/03/251/001-002 | Hepsera | Liechtenstein | 30.4.2008 |
EU/1/03/251/001-002/IS | Hepsera | Islandia | 10.4.2008 |
EU/1/03/253/001/NO-003/NO | Aldurazyme | Norwegia | 30.5.2008 |
EU/1/03/253/001-003 | Aldurazyme | Liechtenstein | 30.6.2008 |
EU/1/03/253/001-003/IS | Aldurazyme | Islandia | 22.5.2008 |
EU/1/06/367/001/NO-012/NO | Diacomit | Norwegia | 7.1.2008 |
EU/1/06/367/001-012 | Diacomit | Liechtenstein | 29.2.2008 |
EU/1/06/367/001-012/IS | Diacomit | Islandia | 7.1.2008 |
EU/1/06/380/001 | Prezista | Liechtenstein | 29.2.2008 |
EU/1/06/380/001/IS | Prezista | Islandia | 22.1.2008 |
EU/1/06/380/001/NO | Prezista | Norwegia | 21.1.2008 |
EU/1/97/045/001-004 | Helicobacter Test INFAI | Liechtenstein | 30.4.2008 |
EU/1/97/045/001-004/IS | Helicobacter Test INFAI | Islandia | 9.4.2008 |
EU/1/97/054/001&004-005/IS | Viracept | Islandia | 21.1.2008 |
EU/1/97/054/001, 004-005 | Viracept | Liechtenstein | 29.2.2008 |
EU/1/97/054/001/NO, 004/NO-005/NO | Viracept | Norwegia | 17.1.2008 |
EU/1/97/055/001/NO-003/NO | Viramune | Norwegia | 21.1.2008 |
EU/1/97/055/001-003 | Viramune | Liechtenstein | 30.4.2008 |
EU/1/97/055/001-003/IS | Viramune | Islandia | 22.1.2008 |
EU/1/97/057/001/IS | Quadramet | Islandia | 7.1.2008 |
EU/1/97/057/001/NO | Quadramet | Norwegia | 17.1.2008 |
EU/1/98/058/001/NO-002/NO | Combivir | Norwegia | 26.2.2008 |
EU/1/98/058/001-002 | Combivir | Liechtenstein | 29.2.2008 |
EU/1/98/058/001-002/IS | Combivir | Islandia | 12.3.2008 |
EU/1/98/063/001/NO-006/NO | Rebif | Norwegia | 3.6.2008 |
EU/1/98/063/001-007 | Rebif | Liechtenstein | 30.6.2008 |
EU/1/98/063/001-007/IS | Rebif | Islandia | 2.6.2008 |
EU/1/98/065/001-002 | Otpison | Liechtenstein | 30.6.2008 |
EU/1/98/066/001/NO-026/NO | Exelon | Norwegia | 3.6.2008 |
EU/1/98/066/001-026 | Exelon | Liechtenstein | 30.6.2008 |
EU/1/98/066/001-026/IS | Exelon | Islandia | 29.5.2008 |
EU/1/98/067/001/NO-002/NO | MabThera | Norwegia | 24.6.2008 |
EU/1/98/067/001-002 | Mabthera | Liechtenstein | 30.6.2008 |
EU/1/98/067/001-002/IS | MabThera | Islandia | 29.5.2008 |
EU/1/98/069/001a/NO-007a/NO; EU/1/98/069/001b/NO-007b/NO; EU/1/98/069/008/NO-010/NO | Plavix | Norwegia | 2.7.2008 |
EU/1/98/069/001a-001b, 002a-002b, 003a-003b, -004a-004b, 005a-005b, 006a-006b, 007a-007b, 008-010 | Plavix | Liechtenstein | 30.6.2008 |
EU/1/98/069/001a-007a& 001b-007b&008-010/IS | Plavix | Islandia | 27.6.2008 |
EU/1/98/070/001a/NO-007a/NO; EU/1/98/070/001b/NO-007b/NO; EU/1/98/070/008/NO-010/NO | Iscover | Norwegia | 2.7.2008 |
EU/1/98/070/001a-001b, 002a-002b, 003a-003b, -004a-004b, 005a-005b, 006a-006b, 007a-007b, 008-010 | Iscover | Liechtenstein | 30.6.2008 |
EU/1/98/070/001a-007a& 001b-007b&008-010/IS | Iscover | Islandia | 27.6.2008 |
EU/1/98/071/001-006 | Xenical | Liechtenstein | 30.6.2008 |
EU/1/98/092/001/NO-023/NO | Prometax | Norwegia | 3.6.2008 |
EU/1/98/092/001-026 | Prometax | Liechtenstein | 30.6.2008 |
EU/1/98/092/001-026/IS | Prometax | Islandia | 16.6.2008 |
EU/2/02/032/001/NO | Vaxxitek HVT + IBD | Norwegia | 24.1.2008 |
EU/2/02/033/001/NO | Dexdomitor | Norwegia | 21.1.2008 |
EU/2/02/034/001/NO | Nobivac Bb dla kotów | Norwegia | 24.1.2008 |
EU/2/02/035/001/NO-007/NO | SevoFlo | Norwegia | 17.1.2008 |
EU/2/02/036/001/NO-002/NO | Nobilis OR inac | Norwegia | 26.2.2008 |
EU/2/02/036/001-002 | Nobilis OR inac | Liechtenstein | 30.4.2008 |
EU/2/02/036/001-002/IS | Nobilis OR inac | Islandia | 21.1.2008 |
EU/2/03/037/005 | ProteqFlu | Liechtenstein | 29.2.2008 |
EU/2/03/037/005/IS | ProteqFlu | Islandia | 21.1.2008 |
EU/2/03/037/005/NO | ProteqFlu | Norwegia | 27.3.2008 |
EU/2/03/038/005 | ProteqFlu-Te | Liechtenstein | 29.2.2008 |
EU/2/03/038/005/IS | ProteqFlu-Te | Islandia | 21.1.2008 |
EU/2/03/038/005/NO | ProteqFlu Te | Norwegia | 27.3.2008 |
EU/2/03/039/001/NO-030/NO | Advocate | Norwegia | 22.4.2008 |
EU/2/03/039/001-004&013-14&019-022/IS | Advocate dla kotów | Islandia | 13.3.2008 |
EU/2/03/039/001-030 | Advocate | Liechtenstein | 29.2.2008 |
EU/2/03/039/005-012&015-018&023-030/IS | Advocate dla psów | Islandia | 13.3.2008 |
EU/2/03/040/001-002 | Gonazon | Liechtenstein | 30.6.2008 |
EU/2/96/002/001/NO-003/NO | Fevaxyn Pentofel | Norwegia | 12.2.2008 |
EU/2/97/001-018/IS | Dicural | Islandia | 21.1.2008 |
EU/2/97/003/001/NO-018/NO | Dicural | Norwegia | 25.2.2008 |
EU/2/97/003/001-018 | Dicural | Liechtenstein | 29.2.2008 |
EU/2/97/004/001&010/IS | Metacam dla bydła i świń | Islandia | 4.1.2008 |
EU/2/97/004/003-005&012-013&016-025&029/IS | Metacam dla psów | Islandia | 4.1.2008 |
EU/2/97/004/006&011/IS | Metacam dla psów i kotów | Islandia | 4.1.2008 |
EU/2/97/004/007-008&014-015&027-028&031-032/IS | Metacam dla bydła, świń i koni | Islandia | 4.1.2008 |
EU/2/97/004/009&030/IS | Metacam dla koni | Islandia | 4.1.2008 |
EU/2/97/004/026/IS | Metcam dla kotów | Islandia | 4.1.2008 |
EU/2/98/006/001-010 | Nobilis IB 4-91 | Liechtenstein | 30.6.2008 |
EU/2/98/006/001-010/IS | Nobilis IB 4-91 | Islandia | 23.5.2008 |
EU/2/98/007/001/NO-003/NO | Clomicalm | Norwegia | 26.5.2008 |
EU/2/98/007/001-003 | Clomicalm | Liechtenstein | 30.4.2008 |
EU/2/98/007/001-003/IS | Clomicalm | Islandia | 21.4.2008 |
EU/2/98/008/001/NO-004/NO | Neocolipor | Norwegia | 21.4.2008 |
EU/2/98/008/001-004 | Neocolipor | Liechtenstein | 30.4.2008 |
EU/2/98/008/001-004/IS | Neocolipor | Islandia | 9.4.2008 |
ZAŁĄCZNIK III
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data przedłużenia pozwolenia |
EU/1/00/143/010/NO-011/NO | Kogenate Bayer | Norwegia | 28.1.2008 |
EU/1/00/143/010-011 | Kogenate Bayer | Liechtenstein | 29.2.2008 |
EU/1/00/143/010-011/IS | Kogenate Bayer | Islandia | 16.1.2008 |
EU/1/00/144/004 | Helixate NexGen | Liechtenstein | 29.2.2008 |
EU/1/00/144/004/IS | Helixate NexGen | Islandia | 16.1.2008 |
EU/1/00/144/004/NO | Helixate NexGen | Norwegia | 28.1.2008 |
EU/1/00/167/008 | Prevenar | Liechtenstein | 30.6.2008 |
EU/1/01/172/006 | Kaletra | Liechtenstein | 30.4.2008 |
EU/1/01/172/006/IS | Kaletra | Islandia | 14.4.2008 |
EU/1/01/172/006/NO | Kaletra | Norwegia | 14.4.2008 |
EU/1/01/195/016/NO-021/NO | Liprolog | Norwegia | 29.1.2008 |
EU/1/01/195/016-021 | Liprolog | Liechtenstein | 29.2.2008 |
EU/1/01/200/002 | Viread | Liechtenstein | 30.4.2008 |
EU/1/01/200/002/NO | Viread | Norwegia | 23.4.2008 |
EU/1/02/213/017-023 | MicardisPlus | Liechtenstein | 30.4.2008 |
EU/1/02/213/017/NO-023/NO | MicardisPlus | Norwegia | 27.5.2008 |
EU/1/02/213/017-023/IS | MicardisPlus | Islandia | 15.4.2008 |
EU/1/02/214/011-015 | Kinzalcomb | Liechtenstein | 30.4.2008 |
EU/1/02/215/015-021 | Pritor Plus | Liechtenstein | 30.4.2008 |
EU/1/02/218/012-029 | Axura | Liechtenstein | 30.6.2008 |
EU/1/02/218/012-029/IS | Axura | Islandia | 28.5.2008 |
EU/1/02/218/016/NO-023/NO | Axura | Norwegia | 27.5.2008 |
EU/1/02/219/016-021 | Ebixa | Liechtenstein | 30.4.2008 |
EU/1/02/219/022/NO-049/NO | Ebixa | Norwegia | 21.5.2008 |
EU/1/02/219/022-049 | Ebixa | Liechtenstein | 30.6.2008 |
EU/1/02/219/022-049/IS | Ebixa | Islandia | 27.5.2008 |
EU/1/03/260/019/NO-023/NO | Stalevo | Norwegia | 27.5.2008 |
EU/1/03/260/019-023 | Stalevo | Liechtenstein | 30.4.2008 |
EU/1/03/260/019-023/IS | Stalevo | Islandia | 20.5.2008 |
EU/1/03/267/008/NO-009/NO | Reyataz | Norwegia | 16.5.2008 |
EU/1/03/267/008-009 | Reyataz | Liechtenstein | 30.4.2008 |
EU/1/03/267/008-009/IS | Reyataz | Islandia | 22.4.2008 |
EU/1/03/268/004 | Cholestagel | Liechtenstein | 30.6.2008 |
EU/1/03/271/001-006/IS | Advate | Islandia | 30.5.2008 |
EU/1/03/271/005/NO-006/NO | Advate | Norwegia | 3.6.2008 |
EU/1/03/271/005-006 | Advate | Liechtenstein | 30.6.2008 |
EU/1/04/274/002 | Velcade | Liechtenstein | 30.4.2008 |
EU/1/04/274/002/NO | Velcade | Norwegia | 21.4.2008 |
EU/1/04/279/036-043 | Lyrica | Liechtenstein | 29.2.2008 |
EU/1/04/283/008/NO-012/NO | Ariclaim | Norwegia | 17.1.2008 |
EU/1/04/283/008-012/IS | Ariclaim | Islandia | 15.2.2008 |
EU/1/04/298/003 | Kivexa | Liechtenstein | 30.4.2008 |
EU/1/04/298/003/NO | Kivexa | Norwegia | 29.2.2008 |
EU/1/06/357/018-021 | Gardasil | Liechtenstein | 30.4.2008 |
EU/1/06/358/018-021 | Silgard | Liechtenstein | 30.4.2008 |
EU/1/06/366/017/NO-022/NO | Tandemact | Norwegia | 22.4.2008 |
EU/1/06/366/017-022 | Tandemact | Liechtenstein | 30.4.2008 |
EU/1/06/366/017-022/IS | Tandemact | Islandia | 16.4.2008 |
EU/1/06/368/058-087 | Insulin Human Winthrop | Liechtenstein | 29.2.2008 |
EU/1/06/370/025-033 | Exforge | Liechtenstein | 30.6.2008 |
EU/1/06/371/025-033 | Dafiro | Liechtenstein | 30.6.2008 |
EU/1/06/372/025-033 | Copalia | Liechtenstein | 30.6.2008 |
EU/1/06/373/025-033 | Imprida | Liechtenstein | 30.6.2008 |
EU/1/07/387/009/NO-010/NO | Advagraf | Norwegia | 25.1.2008 |
EU/1/07/387/009-010 | Advagraf | Liechtenstein | 29.2.2008 |
EU/1/07/388/002 | Sebivo | Liechtenstein | 29.2.2008 |
EU/1/07/388/002/NO | Sebivo | Norwegia | 28.2.2008 |
EU/1/96/006/004/NO-006/NO | NovoSeven | Norwegia | 21.5.2008 |
EU/1/96/006/004-006 | NovoSeven | Liechtenstein | 30.4.2008 |
EU/1/96/006/004-006/IS | NovoSeven | Islandia | 22.5.2008 |
EU/1/96/007/031/NO-038/NO | Humalog | Norwegia | 31.1.2008 |
EU/1/96/007/031-038 | Humalog | Liechtenstein | 29.2.2008 |
EU/1/96/027/006/NO-007/NO | Hycamtin | Norwegia | 9.4.2008 |
EU/1/96/027/006-007 | Hycamtin | Liechtenstein | 30.4.2008 |
EU/1/96/027/006-007/IS | Hycamtin | Islandia | 26.3.2008 |
EU/1/97/030/085-139 | Insuman | Liechtenstein | 29.2.2008 |
EU/1/98/069/008/NO-010/NO | Plavix | Norwegia | 22.4.2008 |
EU/1/98/069/008-010 | Plavix | Liechtenstein | 30.4.2008 |
EU/1/98/069/008-010/IS | Plavix | Islandia | 17.4.2008 |
EU/1/98/070/008/NO-010/NO | Iscover | Norwegia | 19.5.2008 |
EU/1/98/070/008-010 | Iscover | Liechtenstein | 30.4.2008 |
EU/1/98/070/008-010/IS | Iscover | Islandia | 17.4.2008 |
EU/1/99/119/015 | NovoRapid | Liechtenstein | 30.4.2008 |
EU/1/99/119/015/NO | NovoRapid | Norwegia | 25.2.2008 |
EU/2/04/044/007 | Aivlosin | Liechtenstein | 30.6.2008 |
EU/2/04/045/007/NO | Previcox | Norwegia | 29.1.2008 |
EU/2/97/004/031-032 | Metacam | Liechtenstein | 30.6.2008 |
ZAŁĄCZNIK IV
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data wycofania pozwolenia |
EU/1/01/192/001/NO-005/NO | Levviax | Norwegia | 24.1.2008 |
EU/1/02/207/001-020 | Quixidar | Liechtenstein | 30.4.2008 |
EU/1/02/207/001-020/IS | Quixidar | Islandia | 11.3.2008 |
EU/1/02/207/001-020/NO | Quixidar | Norwegia | 2.4.2008 |
EU/1/99/098/001-002 | Zenapax | Liechtenstein | 30.6.2008 |
EU/2/00/025/001-004 | Advasure | Liechtenstein | 30.6.2008 |
© Unia Europejska, http://eur-lex.europa.eu/
Za autentyczne uważa się wyłącznie dokumenty Unii Europejskiej opublikowane w Dzienniku Urzędowym Unii Europejskiej.